Mary Grecco

DocwireNews

Currently, patients diagnosed with mesothelioma have a poor prognosis of about 18 months, and standard treatment with immune checkpoint inhibitor therapy (eg, ipilimumab and nivolumab) usually results in disease progression within 7 months, highlighting an unmet medical need for novel effective treatments. Adoptive cell therapy with autologous tumor-infiltrating lymphocytes (TILs), using a portion of the patient&rsquo;s tumor to develop an individualized immunotherapy, has shown efficacy (including complete response) in other solid tumor indications, and thus was studied to determine its viability as a treatment option for mesothelioma. Results were presented at the WCLC 2023 in Singapore.The study consisted of six patients with mesothelioma who consented to donate tissue at the time of routine pleurectomy decortication, and samples were processed according to pre-Rapid Expansion Protocol (REP) at a 1/10th scale for 11 days and REP at a 1/50th scale for 11 days before being evaluated for dose, purity, identity, activity, and extended phenotyping.Results showed that final TIL products met therapeutically relevant acceptance criteria for five of the six tumor samples (83%). Of the five that met acceptance criteria, the median total of viable cells was 53.4&times;109 cells/mL, purity was 90.1%, and identity phenotype was 98.8%. In addition, TIL were functional and responded to polyclonal bead stimulation; median IFN&gamma; levels were 4454 pg/mL; and TIL products exhibited mixed populations of CD4+ and CD8+ T cells, with a median proportion of CD4+ T cells of 74.5% and CD8+ T cells of 23.3%. The study authors concluded that based on these results, viable TIL can be successfully expanded from mesothelioma tumor tissue.Source: Fennell DA, Poile C, Bzura A, et al. Successful generation of tumor-infiltrating lymphocytes (TIL) for adoptive cell therapy from mesothelioma. Abstract of a poster presented at the 2023 World Conference on Lung Cancer; September 9-12, 2023; Singapore.

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Expanding Viable Tumor-Infiltrating Lymphocytes From Mesothelioma Tumor Tissue

WCLC 2023

Adoptive cell therapy with autologous TILs was studied to determine its viability as a treatment option for mesothelioma.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe